PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Inflammatory discovery sheds new light on skin disease

Inflammatory discovery sheds new light on skin disease
2014-12-02
(Press-News.org) Inflammatory skin diseases such as psoriasis may result from abnormal activation of cell death pathways previously believed to suppress inflammation, a surprise finding that could help to develop new ways of treating these diseases.

Mr James Rickard, Associate Professor John Silke and colleagues from the Walter and Eliza Hall Institute made the discovery while investigating how cell death pathways are linked to inflammatory disease development. The study was published today in the journal eLife.

Infected cells, cancerous cells, or those that are simply unnecessary to the body are instructed to die in a programmed process called apoptosis. Through this process, cells die without affecting or harming surrounding cells, and without mounting an immune response.

Mr Rickard said another recently discovered form of cell death, known as necroptosis, also instructed cells to die by a 'programmed' series of events, with a key difference. "Necroptosis occurs when something has gone wrong with the normal process of apoptosis," Mr Rickard said. "The necroptotic pathway signals that something sinister might be happening, alerting and recruiting key immune cells to the 'scene of the crime'."

Both types of cell death have been implicated in the development of immune disorders, Mr Rickard said. "Previous research has linked necroptosis - or inflammatory cell death - with inflammatory diseases such as psoriasis and, particularly, Crohn's disease."

In the study, the research team looked at how the loss of key molecules involved in either necroptosis or apoptosis affected inflammation and inflammatory disease development.

"We were surprised to discover that apoptosis was the culprit in the development of inflammatory skin disease, while more extensive, system-wide inflammation such as in the liver and spleen was driven by necroptosis," Mr Rickard said. "This was quite unexpected, because apoptosis is not normally associated with inflammation."

A good understanding of necroptosis could help to develop better strategies for treating inflammatory diseases in the future, Associate Professor Silke said.

"This work has also provided us with clues about how existing medications for inflammatory diseases such as psoriasis work, suggesting their effectiveness could be related to their inhibition of apoptosis and necroptosis cell death pathways," he said.

"These existing medications are very effective, however there are significant side-effects. Additionally, these medications do not work for everyone, and can lose their effectiveness over time. By further interrogating these cell death pathways and their role in inflammatory diseases, we may identify new therapeutic targets that provide relief for patients, with drastically reduced side-effects."

Associate Professor Silke said there was still much to discover about necroptosis. "We are only just beginning to understand the complex cascade of signals involved in necroptosis," he said. "It is clear though that necroptosis is very important in our response to infection and disease."

"Scientists from the Walter and Eliza Hall Institute have had great success in unravelling the many complex signals in apoptosis and developing potential treatments based on these findings. A number of teams at the institute, including mine, are now turning their attention to this new cell death pathway, to better understand how it functions in normal and diseased cells. We hope to have the same success and see new treatments based on these fundamental scientific findings in the future," he said.

INFORMATION:

The study was funded by the Australian National Health and Medical Research Council, Australian Cancer Research Foundation, Thomas William and Violet Coles Trust Fund and the Victorian Government.


[Attachments] See images for this press release:
Inflammatory discovery sheds new light on skin disease

ELSE PRESS RELEASES FROM THIS DATE:

Vitamin D deficiency, depression linked in international study

2014-12-02
Vitamin D deficiency is not just harmful to physical health--it also might impact mental health, according to a team of researchers that has found a link between seasonal affective disorder, or SAD, and a lack of sunlight. "Rather than being one of many factors, vitamin D could have a regulative role in the development of SAD," said Alan Stewart of the University of Georgia College of Education. An international research partnership between UGA, the University of Pittsburgh and the Queensland University of Technology in Australia reported the finding in the November ...

Cover crops can sequester soil organic carbon

Cover crops can sequester soil organic carbon
2014-12-02
URBANA, Ill. - A 12-year University of Illinois study shows that, although the use of cover crops does not improve crop yields, the practice does increase the amount of sequestered soil organic carbon using three different soil management systems. U of I soil scientist Ken Olson evaluated plots that were subjected to no-till, chisel plow and moldboard plow treatments with and without hairy vetch and cereal rye cover crops. "By 2012, we found that the soil tillage plots that had cover-crop treatments had more soil organic carbon stock than those without cover crops ...

Triple-negative breast cancer patients should undergo genetic screening: Mayo Clinic

2014-12-02
ROCHESTER, Minn. -- Most patients with triple-negative breast cancer should undergo genetic testing for mutations in known breast cancer predisposition genes, including BRCA1 and BRCA2, a Mayo Clinic-led study has found. The findings come from the largest analysis to date of genetic mutations in this aggressive form of breast cancer. The results of the research appear in the Journal of Clinical Oncology. "Clinicians need to think hard about screening all their triple-negative patients for mutations because there is a lot of value in learning that information, both in ...

Identifying the cellular origin of fibrosis

Identifying the cellular origin of fibrosis
2014-12-02
Researchers from Brigham and Women's Hospital (BWH) have identified what they believe to be the cells responsible for fibrosis, the buildup of scar tissue. Fibrotic diseases, such as chronic kidney disease and failure, lung disease, heart failure and cirrhosis of the liver, are estimated to be responsible for up to 45 percent of deaths in the developed world. The findings are published online in the journal Cell Stem Cell. "Previous research indicated that myofibroblasts are the cells responsible for fibrosis," said Benjamin Humphreys, MD, PhD, senior author of ...

Nutrition, safety key to consumer acceptance of nanotech, genetic modification in foods

2014-12-02
New research from North Carolina State University and the University of Minnesota shows that the majority of consumers will accept the presence of nanotechnology or genetic modification (GM) technology in foods - but only if the technology enhances the nutrition or improves the safety of the food. "In general, people are willing to pay more to avoid GM or nanotech in foods, and people were more averse to GM tech than to nanotech," says Dr. Jennifer Kuzma, senior author of a paper on the research and co-director of the Genetic Engineering in Society Center at NC State. ...

Celiac disease does not increase clinical consultations for fertility problems

2014-12-02
Bethesda, MD (Dec. 2, 2014) -- Women with celiac disease present with fertility problems no more often than women in the general population, according to a new study in Gastroenterology1, the official journal of the American Gastroenterological Association. "Despite inconsistent findings from small studies, concern has been raised that celiac disease may cause infertility," said lead study author Nafeesa N. Dhalwani, PhD, from the University of Nottingham, United Kingdom. "Celiac patients should rest assured; our findings indicate that women with celiac disease do not ...

Researchers control adhesion of E. coli bacteria

2014-12-02
A research team from Kiel University (CAU) and Goethe University Frankfurt has jointly created a synthetic surface on which the adhesion of E. coli bacteria can be controlled. The layer, which is only approximately four nanometres thick, imitates the saccharide coating (glycocalyx) of cells onto which the bacteria adhere such as during an infection. This docking process can be switched on and off using light. This means that the scientists have now made an important step towards understanding the relationship between sugar (carbohydrates) and bacterial infections. Their ...

Tailor-made pharmaceuticals as basis for novel antidepressants

Tailor-made pharmaceuticals as basis for novel antidepressants
2014-12-02
This news release is available in German. The FK506-binding protein 51 (FKBP51) is an established risk factor for stress-related psychiatric disorders such as major depression. Drug discovery for FKBP51 has been hampered by the inability to pharmacologically differentiate against the very similar functional counterplayer FKBP52. Scientists at the Max Planck Institute of Psychiatry in Munich have now developed the first potent and highly selective inhibitor of FKBP51. The so-called SAFit-ligand inhibits FKBP51 enhancing growth of neuronal cell cultures and improving ...

Turn back the molecular clock, say Argentina's plant fossils

Turn back the molecular clock, say Argentinas plant fossils
2014-12-02
Molecular clocks -- based on changes in genetic material -- indicate much younger ages for a wide variety of plants found as fossils in southern Argentina than do the solid, geologic dates of those fossils, according to geoscientists who surveyed recent paleobotanical discoveries in Patagonia. The finding suggests serious biases in molecular clocks, which are heavily used to date many kinds of living things. It also directly refutes a widely-held idea about how most Southern Hemisphere plant and animal groups attained their current distributions. Geologists date fossils ...

Revealed: How bacteria drill into our cells and kill them

2014-12-02
A team of scientists has revealed how certain harmful bacteria drill into our cells to kill them. Their study shows how bacterial 'nanodrills' assemble themselves on the outer surfaces of our cells, and includes the first movie of how they then punch holes in the cells' outer membranes. The research, published today in the journal eLife, supports the development of new drugs that target this mechanism, which is implicated in serious diseases. The team brings together researchers from UCL, Birkbeck, University of London, the University of Leicester, and Monash University ...

LAST 30 PRESS RELEASES:

Azacitidine–venetoclax combination outperforms standard care in acute myeloid leukemia patients eligible for intensive chemotherapy

Adding epcoritamab to standard second-line therapy improves follicular lymphoma outcomes

New findings support a chemo-free approach for treating Ph+ ALL

Non-covalent btki pirtobrutinib shows promise as frontline therapy for CLL/SLL

University of Cincinnati experts present research at annual hematology event

ASH 2025: Antibody therapy eradicates traces of multiple myeloma in preliminary trial

ASH 2025: AI uncovers how DNA architecture failures trigger blood cancer

ASH 2025: New study shows that patients can safely receive stem cell transplants from mismatched, unrelated donors

Protective regimen allows successful stem cell transplant even without close genetic match between donor and recipient

Continuous and fixed-duration treatments result in similar outcomes for CLL

Measurable residual disease shows strong potential as an early indicator of survival in patients with acute myeloid leukemia

Chemotherapy and radiation are comparable as pre-transplant conditioning for patients with b-acute lymphoblastic leukemia who have no measurable residual disease

Roughly one-third of families with children being treated for leukemia struggle to pay living expenses

Quality improvement project results in increased screening and treatment for iron deficiency in pregnancy

IV iron improves survival, increases hemoglobin in hospitalized patients with iron-deficiency anemia and an acute infection

Black patients with acute myeloid leukemia are younger at diagnosis and experience poorer survival outcomes than White patients

Emergency departments fall short on delivering timely treatment for sickle cell pain

Study shows no clear evidence of harm from hydroxyurea use during pregnancy

Long-term outlook is positive for most after hematopoietic cell transplant for sickle cell disease

Study offers real-world data on commercial implementation of gene therapies for sickle cell disease and beta thalassemia

Early results suggest exa-cel gene therapy works well in children

NTIDE: Disability employment holds steady after data hiatus

Social lives of viruses affect antiviral resistance

Dose of psilocybin, dash of rabies point to treatment for depression

Helping health care providers navigate social, political, and legal barriers to patient care

Barrow Neurological Institute, University of Calgary study urges “major change” to migraine treatment in Emergency Departments

Using smartphones to improve disaster search and rescue

Robust new photocatalyst paves the way for cleaner hydrogen peroxide production and greener chemical manufacturing

Ultrafast material captures toxic PFAS at record speed and capacity

Plant phenolic acids supercharge old antibiotics against multidrug resistant E. coli

[Press-News.org] Inflammatory discovery sheds new light on skin disease